rs760867179
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_001039591.3(USP9X):āc.5920A>Gā(p.Ile1974Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000942 in 1,209,575 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 39 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001039591.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP9X | NM_001039591.3 | c.5920A>G | p.Ile1974Val | missense_variant | 35/45 | ENST00000378308.7 | NP_001034680.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP9X | ENST00000378308.7 | c.5920A>G | p.Ile1974Val | missense_variant | 35/45 | 5 | NM_001039591.3 | ENSP00000367558 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000539 AC: 6AN: 111275Hom.: 0 Cov.: 22 AF XY: 0.0000898 AC XY: 3AN XY: 33421
GnomAD3 exomes AF: 0.000285 AC: 52AN: 182163Hom.: 0 AF XY: 0.000266 AC XY: 18AN XY: 67681
GnomAD4 exome AF: 0.0000983 AC: 108AN: 1098248Hom.: 0 Cov.: 32 AF XY: 0.0000990 AC XY: 36AN XY: 363604
GnomAD4 genome AF: 0.0000539 AC: 6AN: 111327Hom.: 0 Cov.: 22 AF XY: 0.0000896 AC XY: 3AN XY: 33483
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Nov 20, 2017 | BS1, BS2, BP4, BP5; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, is predicted to be tolerated by multiple functional prediction tools, and was found in a case with an alternate molecular basis for disease. - |
USP9X-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 23, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at